David Hallal

Mr. David L. Hallal is a Chairman & Chief Executive Officer at AlloVir, Inc., a Chairman at iTeos Therapeutics SA, a Chairman at iTeos Therapeutics, Inc., a Lead Independent Director at Seer, Inc. (California), a Chairman & Chief Executive Officer at ElevateBio LLC, a Chairman at Scholar Rock, Inc. and a Chairman at Scholar Rock Holding Corp. He is on the Board of Directors at Seer, Inc. (California) and Pharmaceutical Research & Manufacturers of America. Mr. Hallal was previously employed as a Chief Executive Officer & Director by Alexion Pharmaceuticals, Inc., a Vice President-Sales by (OSI) Eyetech, a Head-Sales by Biogen Idec, Inc., a Director-Southeast Oncology Sales by Amgen, Inc., and a Director-National Sales by Eyetech Pharmaceuticals, Inc. He received his undergraduate degree from the University of New Hampshire.